Patients with hypertrophic cardiomyopathy (HCM)
Atrial fibrillation and thromboembolism
In patients with hypertrophic cardiomyopathy, atrial fibrillation is common and associated with high thromboembolic risk, warranting anticoagulation, with LA dimension and age being independent predictors.
AF is common in HCM and associated with high thromboembolic risk. LA dimension and age are independently associated with AF but the literature is insufficient to create robust clinical tools to predict AF or thromboembolism. Most data suggest that AF patients should be anticoagulated.
Building similarity graph...
Analyzing shared references across papers
Loading...
Oliver Guttmann
Interventional Cardiology
Mohammad Shafiqur Rahman
Chittagong University of Engineering & Technology
Constantinos O’Mahony
Interventional Cardiology
Heart
University College London
National and Kapodistrian University of Athens
University of Dhaka
Building similarity graph...
Analyzing shared references across papers
Loading...
Guttmann et al. (Sat,) studied this question.
synapsesocial.com/papers/69c5e6dc7090fce65e4ad853 — DOI: https://doi.org/10.1136/heartjnl-2013-304276